ePostersMultiple Sclerosis Journal, Volume 23, Issue 3_suppl, Page 680-975, October 2017. … read morePosted At: MS Journal
Rituximab is an acceptable alternative to ocrelizumab for treating multiple sclerosis – NoMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Revisiting cognitive reserve and cognition in multiple sclerosis: A closer look at depressionMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Trial Suggests Cholesterol-Lowering Drug May Prove Beneficial for People with Secondary-Progressive/About-the-Society/News/Trial-Suggests-Cholesterol-Lowering-Drug-May-Prove … read morePosted At: National MS Society
Researchers Identify Toxin That They Suggest May Be a Trigger for MS: Studies Proceed with Society F
Researchers Identify Toxin That They Suggest May Be a Trigger for MS: Studies Proceed with Society F/About-the-Society/News/Researchers-Identify-Toxin-That-They-Suggest-May-B … read morePosted At: National MS Society
Join Our Mailing List
- Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis
- What are the early signs of MS?
- Silent lesions on MRI imaging – Shifting goal posts for treatment decisions in multiple sclerosis
- Treatment decisions in MS: Shifting the goal posts or changing how we see them?
- How to give an intramuscular injection
- Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry
- e-Health and multiple sclerosis: An update
- Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System
- Glutamate-sensitive imaging and evaluation of cognitive impairment in multiple sclerosis
- MS: Is a ‘rogue’ brain and lymph node interaction to blame?